Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum

Lignende værker

• Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis
  af: Charrier, Cedric, et al.
  Udgivet: (2014)
• Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex
  af: Fraser-Pitt, Douglas, et al.
  Udgivet: (2016)
• An Open-Label Investigation of the Pharmacokinetics and Tolerability of Oral Cysteamine in Adults with Cystic Fibrosis
  af: Devereux, Graham, et al.
  Udgivet: (2016)
• Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial
  af: Devereux, Graham, et al.
  Udgivet: (2020)
• Cystic fibrosis – a multiorgan protein misfolding disease
  af: Fraser-Pitt, Douglas, et al.
  Udgivet: (2015)